OWL > Scientific articles

Selected scientific articles

Pub Med web site lets you search all these articles citations and abstracts: www.ncbi.nlm.nih.gov/pubmed


Icosabutate exerts beneficial effects upon insulin sensitivity, hepatic inflammation, lipotoxicity and fibrosis in mice

van den Hoek AM, et al.

Hepatol Commun. 2020;4(2):193-207



The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles

Matorras R, et al.

Journal of Assisted Reproduction and Genetics 2020 doi: 10.1007/s10815-019-01670-z.



Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease

Mato JM, et al.

World J Gastroenterol. 2019;25(24):3009-20.



Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis

Banales JM, et al.

Hepatology 2019;70(2):547-62.



Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis

Michelena J, et al.

Ann Hepatol. 2019;18(1):144-54



Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

Reverter E, et al.

Liver Int. 2019;39(4):705-13



A Slow-Digesting Carbohydrate Diet during Rat Pregnancy Protects Offspring from Non-Alcoholic Fatty Liver Disease Risk through the Modulation of the Carbohydrate-Response Element and Sterol Regulatory Element Binding Proteins

Salto R, et al.

Nutrients 2019;11(4):844



Differences in the metabolite composition and mechanical properties of extracellular vesicles secreted by hepatic cellular models

Royo F, et al.

J Extracell Vesicles. 2019;8(1),1575678



Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts

Mayo R, et al.

Hepatol Commun. 2018;2(7):807-20



Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease

Chalasani N, et al.

Aliment Pharmacol Ther. 2018;47(12):1639-51



Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-.Leiden Mice

Morrison MC, et al.

Hepatol Commun 2018;2(12):1513-32



Use of a Metabolomic Approach to Non-invasively Diagnose Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

Bril F, et al.

Diabetes Obes Metab. 2018;20(7):1702-9



Feeding a slowly digestible carbohydrate diet during pregnancy of insulin-resistant rats prevents the excess of adipogenesis in their offspring

Martin MJ, et al.

Journal of Nutritional Biochemistry 2018;61:183-96



Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer

Cubiella J, et al.

Cancers 2018;10(9):300; doi:10.3390/cancers10090300



Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression

Clos-García M, et al.

J Extracell Vesicles. 2018;7(1):1470442



The fatty acids of sphingomyelins and ceramides in mammalian tissues and cultured cells: biophysical and physiological implications.

Manni MM, et al.

Chem Phys Lipids. 2018; 217:29-34



Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

Alonso C, et al.

Gastroenterology 2017;152(6):1449-61



A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients

Cano A, et al.

Sci Rep. 2017;5;7:10497



Role of Aramchol in steatohepatitis and fibrosis in mice

Iruarrizaga-Lejarreta M, et al.

Hepatol Commun. 2017;1:911-927



Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis

Røpke MA, et al.

J Dermatol Sci. 2017;88:330-8



Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.

Arbelaiz A, et al.

Hepatology. 2017;66:1125-1143



Metabolically active extracellular vesicles released from hepatocytes under drug-induced liver-damaging conditions modify serum metabolome and might affect different pathophysiological processes

Royo F, et al.

Eur J Pharm Sci. 2017;98:51-57



Lipidomic profile of GM95 cell death induced by Clostridium perfringens alpha-toxin.

Manni M, et al.

Chem Phys Lipids. 2017;203:54-70



Metabolomic signatures associated with disease severity in multiple sclerosis

Villoslada P, et al.

Neurology: Neuroimmunology & Neuroinflammation 2017;4(2):e321



Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension

Seijó S, et al.

Liver Int. 2016;36(7):1051-8



Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy

Embade N, et al.

PLoS One 2016;11(5):e0155094



Enhancing metabolomics research through data mining

Martinez-Arranz, I et al.

J Proteomics 2015;127(B):275-88



Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer

Barbier-Torres L, et al.

Oncotarget 2015;6(4):2509-23



Lipids that determine detergent resistance of MDCK cell membrane fractions.

Manni MM, et al.

Chemistry and Physics of Lipids 2015;191:68-74



The Metabolomic Profile of Spent Culture Media from Day-3 Human Embryos Cultured under Low Oxygen Tension

De los Santos, et al.

PLoS One 2015;10(11):e0142724



Deciphering non-alcoholic fatty liver disease through metabolomics

Cano A and Alonso C

Biochem Soc Trans. 2014;42(5):1447-52



High-melting lipid mixtures and the origin of detergent-resistant membranes studied with temperature-solubilization diagrams

Sot J, et al.

Biophysical Journal 2014;107(12):2828-37.



Nonalcoholic fatty liver disease

Alonso C and Mato JM

Chapter in: Global Metabolic Profiling: Clinical Applications
eBook ISBN: 978-1-909453-61-6 (Future Science Ltd) 2014



Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis

Martínez-Uña M, et al.

Hepatology 2013; 58(4):1296-305



Obesity-dependent metabolic signatures associated with nonalcoholic Fatty liver disease progression.

Barr J, et al.

Journal of Proteome Research 2012;11(4),2521-32



Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease.

Vazquez-Chantada M, et al.

Hepatology 2013;57(2):505-14



Metabolomics Discloses Potential Biomarkers for the Noninvasive Diagnosis of Idiopathic Portal Hypertension.

Seijo S, et al.

The American Journal of Gastroenterology 2013;108(6):926-32



Effect of vitrification on human oocytes: a metabolic profiling study

Dominguez F, et al.

Fertility and Sterility 2013,99(2):565-72



Liquid Chromatography-Mass Spectrometry (LC/MS)-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of non-alcoholic fatty liver disease.

Barr J, et al.

Journal of Proteome Research 2010;9(9),4501-12



Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity

González E, et al.

Metabolomics 2012;8(6):997-1011



Back to top


OWL is a trading name of
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
+34 94 431 85 40

With this web OWL intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a
qualified physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 02/20/2020

With the collaboration of: